Study for the mechanism of immune inflammatory injury induced by dipeptidase 4 to T lymphocytes in sjogren's syndrome

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033355

Enrollment

Unknown

Registered

2020-05-29

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's Syndrome

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Included in the clinical diagnosis of SS patients; 2. Patients between 18-65 years old; 3. Exclude the influence of tumor, radiotherapy and chemotherapy; 4. Exclude the influence of mixed connective tissue disease.

Exclusion criteria

Exclusion criteria: 1. The clinical diagnosis of SS was secondary to mixed connective tissue disease; 2. SS patients with tumor or undergoing radiotherapy and chemotherapy; 3. SS clinical patients who are not willing to provide information.

Design outcomes

Primary

Measure	Time frame
anti-SSA;anti-SSB;	—

Countries

China

Contacts

Public ContactNaidan Zhang

Deyang people's Hospital

znd1984@126.com+86 15883444219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026